Clinical trial registry record

Effect of Creatine+HMB Supplementation in Physically Active Older Adults

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated August 29, 2025.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT05951439
Last registry update
August 29, 2025
Status
Completed
Phase
Phase not reported
Sponsor
Universidad de Burgos
Enrollment
30
Countries
Spain
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · CROSSOVER · PREVENTION · TRIPLE
Evidence population
Human clinical study registration
Participants
30
Population
ALL · 55 Years to 80 Years
Duration
2024-11-08 to 2025-02-22
Intervention
CRE + HMB; Placebo
Comparator
Intervention Group 2
Outcomes measured
Body composition (Day 0 and at 6 weeks of intervention). — 6 weeks; Body composition (Day 0 after 3 weeks washout and at 6 weeks of intervention). — 6 weeks; Nutritional evaluation (Day 0 and at 6 weeks of intervention). — 6 weeks; Nutritional evaluation (Day 0 after 3 weeks washout and at 6 weeks of intervention). — 6 weeks; Assessment of muscle strength and performance. Short Physical Performance Battery (Day 0 and at 6 weeks of intervention…; Assessment of muscle strength and performance. Short Physical Performance Battery (Day 0 after 3 weeks washout and at 6…; Assessment of muscle strength and performance. Timed-up-and-go (Day 0 and at 6 weeks of intervention). — 6 weeks; Assessment of muscle strength and performance. Timed-up-and-go (Day 0 after 3 weeks washout and at 6 weeks of intervent…; Assessment of muscle strength and performance. 400-meter Walk Test Perfomance (Day 0 and at 6 weeks of intervention). —…; Assessment of muscle strength and performance. 400-meter Walk Test Perfomance (Day 0 after 3 weeks washout and at 6 wee…; Assessment of muscle strength and performance. Grip strength (Day 0 and at 6 weeks of intervention). — 6 weeks; Assessment of muscle strength and performance. Grip strength (Day 0 after 3 weeks washout and at 6 weeks of interventio…; Isometric strength of legs and back (Day 0 and at 6 weeks of intervention) — 6 Weeks; Isometric strength of legs and back (Day 0 after 3 weeks washout and at 6 weeks of intervention). — 6 Weeks; Isometric arm flexion strength (Day 0 and at 6 weeks of intervention) — 6 Weeks; Isometric arm flexion strength (Day 0 after 3 weeks washout and at 6 weeks of intervention) — 6 Weeks; 30-second push-up test (Day 0 and at 6 weeks of intervention) — 6 Weeks; 30-second push-up test (Day 0 after 3 weeks washout and at 6 weeks of intervention) — 6 Weeks; 30-second supine trunk flexion test (Day 0 and at 6 weeks of intervention) — 6 Weeks; 30-second supine trunk flexion test (0 day after 3 weeks washout and at 6 weeks of intervention) — 6 Weeks
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Creatine and ageing · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Title supplies ageing or longevity context.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.